FindTrial
Sign In

Use of MRI in gastric cancer for detecting spread of tumour in peritoneum

â??Utility of MRI in detecting peritoneal metastases in gastric cancer patients with negative CECT abdomenâ??

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/07/015012
Enrollment
65
Registered
2018-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C169- Malignant neoplasm of stomach, unspecified

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with non-metastatic gastric cancer on baseline CECT who are planned for staging laparoscopy/ upfront surgery.

Exclusion criteria

Exclusion criteria: 1. Patients who cannot undergo an optimal MRI 2. Patients who refuse consent for the study

Design outcomes

Primary

MeasureTime frame
Evaluate the sensitivity, specificity, and the positive and negative predictive value of MRI in detecting peritoneal disease in gastric cancer patients with non-metastatic disease on baseline CECT and correlate with staging laparoscopy findings/ upfront surgery.Timepoint: 2 years—

Secondary

MeasureTime frame
Presence or absence of peritoneal disease on MRI compared to surgical findingsTimepoint: 2 years—

Countries

India

Contacts

Public ContactAkshay Baheti

Tata Memorial Hospital

akshaybaheti@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026